IRIS
DI MINNO, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 12.817
NA - Nord America 11.443
EU - Europa 7.358
SA - Sud America 1.672
Continente sconosciuto - Info sul continente non disponibili 755
AF - Africa 310
OC - Oceania 19
Totale 34.374
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.862
SG - Singapore 6.396
RU - Federazione Russa 3.582
CN - Cina 2.007
VN - Vietnam 1.972
BR - Brasile 1.343
HK - Hong Kong 1.310
IT - Italia 905
FR - Francia 497
DE - Germania 495
FI - Finlandia 495
CA - Canada 312
IE - Irlanda 271
NL - Olanda 227
UA - Ucraina 212
GB - Regno Unito 200
JP - Giappone 180
SE - Svezia 173
BD - Bangladesh 163
IN - India 159
MX - Messico 126
AR - Argentina 123
IQ - Iraq 99
ZA - Sudafrica 78
PH - Filippine 70
ES - Italia 65
ID - Indonesia 57
CI - Costa d'Avorio 55
PK - Pakistan 55
EC - Ecuador 53
KR - Corea 52
PL - Polonia 51
CO - Colombia 47
TH - Thailandia 45
AT - Austria 39
TW - Taiwan 35
TR - Turchia 34
JM - Giamaica 30
CL - Cile 24
MA - Marocco 24
VE - Venezuela 24
SA - Arabia Saudita 23
UZ - Uzbekistan 22
EG - Egitto 20
PY - Paraguay 19
JO - Giordania 18
KE - Kenya 17
PE - Perù 17
TN - Tunisia 16
NI - Nicaragua 15
NP - Nepal 15
AE - Emirati Arabi Uniti 14
BG - Bulgaria 14
CR - Costa Rica 14
CH - Svizzera 13
CZ - Repubblica Ceca 13
TT - Trinidad e Tobago 13
GT - Guatemala 12
HN - Honduras 12
SN - Senegal 12
RO - Romania 11
BE - Belgio 10
RS - Serbia 10
UY - Uruguay 10
DO - Repubblica Dominicana 9
ET - Etiopia 9
MY - Malesia 9
AO - Angola 8
AU - Australia 8
BO - Bolivia 8
DZ - Algeria 8
EE - Estonia 8
EU - Europa 8
AZ - Azerbaigian 7
BB - Barbados 7
GR - Grecia 7
IR - Iran 7
KZ - Kazakistan 7
NG - Nigeria 7
SV - El Salvador 7
HU - Ungheria 6
IL - Israele 6
LT - Lituania 6
LU - Lussemburgo 6
PT - Portogallo 6
GH - Ghana 5
KG - Kirghizistan 5
LC - Santa Lucia 5
MN - Mongolia 5
PA - Panama 5
BA - Bosnia-Erzegovina 4
BF - Burkina Faso 4
CY - Cipro 4
HR - Croazia 4
KW - Kuwait 4
LA - Repubblica Popolare Democratica del Laos 4
ML - Mali 4
NC - Nuova Caledonia 4
OM - Oman 4
PS - Palestinian Territory 4
Totale 33.506
Salva come PNG Salva come JPEG
Città #
Singapore 2.736
San Jose 2.006
Hong Kong 1.265
Moscow 852
Ashburn 620
Chandler 614
Ho Chi Minh City 565
Santa Clara 502
The Dalles 476
Hanoi 457
Princeton 445
Beijing 430
Boston 394
Lauterbourg 391
Millbury 380
Los Angeles 277
Nanjing 274
Amsterdam 203
Council Bluffs 200
Jacksonville 200
Hefei 187
Buffalo 185
Naples 164
Ottawa 156
Tokyo 147
Wilmington 145
São Paulo 130
Redondo Beach 125
New York 120
Napoli 109
Des Moines 100
Phoenix 99
Munich 96
Haiphong 89
Nanchang 89
Dallas 88
Boardman 87
Da Nang 83
Menlo Park 80
Seattle 70
Hebei 67
Houston 63
Shenyang 63
Falls Church 61
Mexico City 61
Norwalk 60
Orem 60
Turku 55
Nuremberg 54
Chicago 50
Tianjin 50
Jiaxing 47
Rome 46
Brooklyn 45
Warsaw 44
Frankfurt am Main 43
Baghdad 41
Denver 39
Montreal 39
Atlanta 38
Milan 38
Johannesburg 36
Rio de Janeiro 36
San Francisco 36
Changsha 33
Hải Dương 32
Chennai 31
Stockholm 30
Biên Hòa 29
Toronto 28
Dublin 27
Kronberg 26
Brasília 25
Helsinki 25
Can Tho 24
Curitiba 24
Kerken 24
Dhaka 23
Krefeld 23
Lawrence 22
Nocera Inferiore 22
Seoul 22
Woodbridge 22
London 21
Castellón 20
Tashkent 20
Guayaquil 19
Kingston 19
Manchester 19
Philadelphia 19
Redwood City 19
Vienna 19
Thái Nguyên 18
Amman 17
Ann Arbor 17
Bangkok 17
Ribeirão Preto 17
Belo Horizonte 16
Kunming 16
Redmond 16
Totale 17.609
Salva come PNG Salva come JPEG
Nome #
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 237
Perspective - The case for zero bleeds and drug bioequivalence in the treatment of congenital hemophilia A in 2021 204
The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry 199
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 198
111° Congresso SIMI 194
New data from the italian national register of congenital coagulopathies, 2016 annual survey 178
Spontaneous Muscle Hematoma in Patients with COVID-19: A Systematic Literature Review with Description of an Additional Case Series 163
Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study 151
Long-lasting intestinal bleeding in an old patient with multiple mucosal vascular abnormalities and Glanzmann's thrombasthenia: 3-year pharmacological management. 143
Perioperative handling of patients on antiplatelet therapy with need for surgery. 143
Anticoagulant Therapy in Oncologic Patients Undergoing Venous Stenting for Superior Vena Cava Syndrome and Other Interventional Procedures. 141
“A fast and accurate method for genotyping the Angiotensin-Converting Enzyme (ACE) I/D polymorphism” 139
RASopathies and hemostatic abnormalities: key role of platelet dysfunction 137
Right-to-left shunt, atrial septal aneurysm and thrombophilia in patients with cryptogenic stroke or TIA vs. those with venous thrombo-embolism 137
Antiphospholipid syndrome, adrenal failure, dilated cardiomyopathy and chronic hepatitis: an unusual manifestation of multiorgan autoimmune injury? 136
Aberrant F8 gene intron 1 inversion with concomitant duplication and deletion in a severe hemophilia A patient from Southern Italy. 134
Acquired Factor v Inhibitor after Coronavirus Disease 2019 (COVID-19) 132
Haemophilia A: molecular insights. 131
Risk factors and recurrent thrombotic episodes in patients with cerebral venous thrombosis 131
Endothelin abnormalities in patients with pulmonary embolism. 130
Diabetes,vascular complications and antiplatelet therapy: open problems 130
Antithrombotic drugs, patient characteristics, and gastrointestinal bleeding: Clinical translation and areas of research 130
Prognostic relevance of oxidative stress measurement in chronic lymphocytic leukaemia 129
Acquired haemophilia a in the elderly: case reports. 128
The challenge of diagnosing pulmonary embolism in children, pregnant women, and elderly patients: a descriptive review of the literature. 127
Emergency management in patients with haemophilia A and inhibitors on prophylaxis with emicizumab: AICE practical guidance in collaboration with SIBioC, SIMEU, SIMEUP, SIPMeL and SISET 127
The infectious burden in atherothrombosis. 126
Oxidative stress and plateletactivation in homozygous homocystinuria 125
Mutational spectrum of F8 gene and prothrombotic gene variants in haemophilia A patients from Southern Italy. 125
The risk of gastrointestinal bleeding in patients receiving dabigatran etexilate: a systematic review and meta-analysis of the literature 125
Can serum TGF-beta 1 be used to evaluate the response to antiviral therapy of haemophilic patients with HCV-related chronic hepatitis? 124
Venous thromboembolism in covid-19 compared to non-covid-19 cohorts: A systematic review with meta-analysis 124
Acute coronary syndrome and severe haemophilia: an unusual association with challenging treatment. 123
A fast and accurate method for genotyping the angiotensin-converting enzyme I/D polymorphism. 122
ANMCO Position Paper: Long-term follow-up of patients with pulmonary thromboembolism 122
Cardiac Manifestations of Antiphospholipid Syndrome: Clinical Presentation, Role of Cardiac Imaging, and Treatment Strategies 122
Hemostatic variables in homozygous familial hypercholesterolemia. Effect of regular plasma cholesterol removal by low density lipoprotein apheresis. 121
Predicting early and delayed bleedings in children who undergo adeno-tonsillectomy surgery. Is it really possible? 121
Benefits of prophylaxis versus on-demand treatment in adolescents and adults with severe haemophilia A: The POTTER study 121
Awareness of individual goals, preferences, and priorities of persons with severe congenital haemophilia A for a tailored shared decision-making approach to liver-directed gene therapy. A practical guideline 120
Prevention of venous thromboembolism in medical patients with thrombocytopenia or with platelet dysfunction: a review of the literature. 120
Absence of apolipoprotein B3500 mutation in type 2a hyperlipoproteinemia patients and in the general population from southern Italy. 120
HELLP syndrome and its relation with the antiphospholipid syndrome. 120
Methylation reactions, the redox balance and atherothrombosis: the search for a link with hydrogen sulfide 119
IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII 119
Attempting to remedy sub-optimal medication adherence in haemophilia: The rationale for repeated ultrasound visualisations of the patient's joint status 118
Improving assessment and management of pain in hemophilia: an Italian Delphi consensus statement 118
Asymptomatic and symptomatic deep venous thrombosis in hospitalized acutely ill medical patients: risk factors and therapeutic implications 117
[Absence of an association of the D allele of the ACE gene with arterial pressure in mild-moderate essential arterial hypertension]. 117
Systematic reviews and meta-analyses for more profitable strategies in peripheral artery disease. 117
Denaturing HPLC procedure for factor IX gene scanning 116
Neutrophil extracellular traps as an adhesion substrate for different tumor cells expressing RGD-binding integrins. 115
Paradigm shift for the treatment of hereditary haemophilia: Towards precision medicine 115
Diabetes mellitus and cardiovascular prevention: the role and the limitations of currently available antiplatelet drugs. 114
The first ambulatory screening on thromboembolism: a multicentre, cross-sectional, observational study on risk factors for venous thromboembolism. 113
Prevalence of deep vein thrombosis and pulmonary embolism in patients with superficial vein thrombosis: A systematic review and meta-analysis 112
Gastrointestinal bleeding in patients receiving oral anticoagulation: Current treatment and pharmacological perspectives 112
Biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis 112
I nuovi anticoagulanti orali: Raccomandazioni, precauzionie prospettive d'uso 111
Comparative analysis of the pivotal studies of extended half-life recombinant FVIII products for treatment of haemophilia A 111
Venous thromboembolism: which patients are truly at risk? 110
Natural anticoagulants deficiency and the risk of venous thromboembolism: A meta-analysis of observational studies 110
Left ventricular diastolic abnormalities other than valvular heart disease in antiphospholipid syndrome: An echocardiographic study 110
Low Rate of Intrahospital Deep Venous Thrombosis in Acutely Ill Medical Patients: Results From the AURELIO Study 108
The "antiphospholipid triangle" in an asymptomatic patient: a case report. 108
Aspirin for preventing the recurrence of venous thromboembolism. 107
Ensuring medication adherence with direct oral anticoagulant drugs: lessons from adherence with vitamin K antagonists (VKAs). 107
Thrombosis in Autoimmune Diseases: A Role for Immunosuppressive Treatments? 107
The risk of venous thromboembolism in patients with cirrhosis. A systematic review and meta-analysis 106
ABNORMALLY HIGH THROMBOXANE BIOSYNTHESIS IN HOMOZYGOUS HOMOCYSTINURIA. EVIDENCE FOR PLATELET INVOLVEMENT AND PROBUCOL-SENSITIVE MECHANISM. 105
Transient global amnesia in a young woman on prolonged treatment with oral contraceptive drugs. 105
Carotid intima-media thickness in psoriatic arthritis: Differences between tumor necrosis factor-α blockers and traditional disease-modifying antirheumatic drugs 105
Consensus statements on vaccination in patients with haemophilia—Results from the Italian haemophilia and vaccinations (HEVA) project 105
Prevalence of apolipoprotein E alleles in healthy subjects and survivors of ischemic stroke: an Italian Case-Control Study 104
Arthropathy in patients with moderate hemophilia A: A systematic review of the literature 104
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry 103
Uncomplicated type 1 diabetes and preclinical left ventricular myocardial dysfunction: insights from echocardiography and exercise cardiac performance evaluation. 102
Molecular analysis and genotype-phenotype correlation in patients with antithrombin deficiency from Southern Italy. 102
Improving the use of direct oral anticoagulants in atrial fibrillation 102
Serum concentrations of the tissue polypeptide specific antigen in patients suffering from non-alcoholic steatohepatitis 101
The real effectiveness of ultrasound guidance in subclavian venous access. 101
Pain assessment and management in Italian Haemophilia Centres 101
Noninvasive assessment of liver fibrosis in patients with chronic hepatitis C (and congenital bleeding disorders): where do we stand? 100
Cost of care of haemophilia with inhibitors. 99
Nutrition, Metabolism, Cardiovascular Disease 99
Cardiovascular Risk in Rheumatic Patients: The Link between Inflammation and Atherothrombosis. 96
Hyperhomocysteinemia and other inherited prothrombotic conditions in young adults with a history of ischemic stroke. 96
Diabetes and cardiovascular disease: Thrombotic risk and aspirin-resistance. 96
Insight into the nature of the CRP-coronary event association using Mendelian randomization. 95
“Structural and functional cardiovascular abnormalities in never-treated hypertensives according to ACE-gene polymorphism” 94
A role for von Willebrand factor in immune tolerance induction in patients with haemophilia A and inhibitors? 94
Factor V Leiden, C > T MTHFR polymorphism and genetic susceptibility to preeclampsia. 94
Association of TERC and OBFC1 haplotypes with mean leukocyte telomere length and risk for coronary heart disease. 94
Italian intersociety consensus on DOAC use in internal medicine 94
Physical activity improved by adherence to prophylaxis in an Italian population of children, adolescents and adults with severe haemophilia A: The SHAPE Study 94
Management of ischemic heart disease in hemophiliac patients: new challenges from a case report and review of the literature 93
Increased binding of fibrinogen to platelets in diabetes: the role of prostaglandins and thromboxane. 93
Integrin-dependent cell adhesion to neutrophil extracellular traps through engagement of fibronectin in neutrophil-like cells 93
From unfractionated heparin to pentasaccharide: Paradigm of rigorous science growing in the understanding of the in vivo thrombin generation 93
Therapeutic management and costs of severe haemophilia A patients with inhibitors in Italy 92
Totale 11.988
Salva come PNG Salva come JPEG
Categoria #
all - tutte 126.326
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 126.326
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.826 0 0 2 5 11 30 21 76 274 107 188 1.112
2022/20231.787 480 88 28 116 168 154 1 177 286 177 94 18
2023/20241.323 39 195 169 67 35 26 106 96 10 7 383 190
2024/20259.125 603 895 22 92 98 324 852 466 1.296 1.005 2.659 813
2025/202615.538 1.883 1.043 1.399 1.290 2.733 676 1.727 956 2.237 996 307 291
2026/20271.418 372 419 627 0 0 0 0 0 0 0 0 0
Totale 34.374